411 related articles for article (PubMed ID: 8393525)
1. Molecular cloning and functional expression of a mu-opioid receptor from rat brain.
Chen Y; Mestek A; Liu J; Hurley JA; Yu L
Mol Pharmacol; 1993 Jul; 44(1):8-12. PubMed ID: 8393525
[TBL] [Abstract][Full Text] [Related]
2. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
[TBL] [Abstract][Full Text] [Related]
3. Cloning, heterologous expression and pharmacological characterization of a kappa opioid receptor from the brain of the rough-skinned newt, Taricha granulosa.
Bradford CS; Walthers EA; Searcy BT; Moore FL
J Mol Endocrinol; 2005 Jun; 34(3):809-23. PubMed ID: 15956349
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
Puttfarcken PS; Werling LL; Cox BM
Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
Kazmi SM; Mishra RK
Mol Pharmacol; 1987 Jul; 32(1):109-18. PubMed ID: 3037297
[TBL] [Abstract][Full Text] [Related]
6. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
7. The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain.
Simonin F; Befort K; Gavériaux-Ruff C; Matthes H; Nappey V; Lannes B; Micheletti G; Kieffer B
Mol Pharmacol; 1994 Dec; 46(6):1015-21. PubMed ID: 7808419
[TBL] [Abstract][Full Text] [Related]
8. Direct measurements of in situ interactions of rat brain opioid receptors with the guanine nucleotide-binding protein Go.
Georgoussi Z; Carr C; Milligan G
Mol Pharmacol; 1993 Jul; 44(1):62-9. PubMed ID: 8393523
[TBL] [Abstract][Full Text] [Related]
9. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
Minami M; Nakagawa T; Seki T; Onogi T; Aoki Y; Katao Y; Katsumata S; Satoh M
Mol Pharmacol; 1996 Nov; 50(5):1413-22. PubMed ID: 8913373
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a delta opioid receptor in rat pheochromocytoma cells.
Abood ME; Tao Q
J Pharmacol Exp Ther; 1995 Sep; 274(3):1566-73. PubMed ID: 7562535
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the cloned human mu opioid receptor.
Raynor K; Kong H; Mestek A; Bye LS; Tian M; Liu J; Yu L; Reisine T
J Pharmacol Exp Ther; 1995 Jan; 272(1):423-8. PubMed ID: 7815359
[TBL] [Abstract][Full Text] [Related]
12. The mu-opioid receptor down-regulates differently from the delta-opioid receptor: requirement of a high affinity receptor/G protein complex formation.
Chakrabarti S; Yang W; Law PY; Loh HH
Mol Pharmacol; 1997 Jul; 52(1):105-13. PubMed ID: 9224819
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
Knapp RJ; Santoro G; De Leon IA; Lee KB; Edsall SA; Waite S; Malatynska E; Varga E; Calderon SN; Rice KC; Rothman RB; Porreca F; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1996 Jun; 277(3):1284-91. PubMed ID: 8667189
[TBL] [Abstract][Full Text] [Related]
14. Human mu-opioid receptor overexpressed in baculovirus system and its pharmacological characterizations.
Wei Q; Zhou DH; Shen QX; Wang CH; Chen J; Li CL; Pei G; Chi ZQ
Zhongguo Yao Li Xue Bao; 1998 May; 19(3):218-22. PubMed ID: 10375729
[TBL] [Abstract][Full Text] [Related]
15. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.
Murthy KS; Makhlouf GM
Mol Pharmacol; 1996 Oct; 50(4):870-7. PubMed ID: 8863832
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and functional analysis of the rat mu opioid receptor gene promoter.
Kraus J; Horn G; Zimprich A; Simon T; Mayer P; Höllt V
Biochem Biophys Res Commun; 1995 Oct; 215(2):591-7. PubMed ID: 7487996
[TBL] [Abstract][Full Text] [Related]
17. Characterization and distribution of a cloned rat mu-opioid receptor.
Bunzow JR; Zhang G; Bouvier C; Saez C; Ronnekleiv OK; Kelly MJ; Grandy DK
J Neurochem; 1995 Jan; 64(1):14-24. PubMed ID: 7798908
[TBL] [Abstract][Full Text] [Related]
18. The bovine mu-opioid receptor: cloning of cDNA and pharmacological characterization of the receptor expressed in mammalian cells.
Onoprishvili I; Andria ML; Vilim FS; Hiller JM; Simon EJ
Brain Res Mol Brain Res; 1999 Nov; 73(1-2):129-37. PubMed ID: 10581406
[TBL] [Abstract][Full Text] [Related]
19. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.
Lu YF; Xu H; Liu-Chen LY; Chen C; Partilla JS; Brine GA; Carroll FI; Rice KC; Lai J; Porreca F; Sadee W; Rothman RB
Synapse; 1998 Feb; 28(2):117-24. PubMed ID: 9450512
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
Zernig G; Burke T; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1996 Oct; 279(1):23-31. PubMed ID: 8858971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
